| Identification | Back Directory | [Name]
IlexgeninA | [CAS]
108524-94-3 | [Synonyms]
IlexgeninA
Myriaboric acid
Urs-12-ene-23,28-dioicacid, 3,19-dihydroxy-, (3b,4b)-
Urs-12-ene-23,28-dioic acid, 3,19-dihydroxy-, (3β,4β)-
(3beta,4beta)-3,19-Dihydroxy-urs-12-ene-23,28-dioic acid | [Molecular Formula]
C30H46O6 | [MDL Number]
MFCD30724959 | [MOL File]
108524-94-3.mol | [Molecular Weight]
502.68 |
| Chemical Properties | Back Directory | [Boiling point ]
653.3±55.0 °C(Predicted) | [density ]
1.23±0.1 g/cm3(Predicted) | [form ]
Solid | [pka]
4.46±0.70(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
Ilexgenin A is a novel pentacyclic triterpenoid which has been shown to exhibit effects reducing LPS-induced peritonitis in mammals. | [in vivo]
Ilexgenin A (20 mg/kg) ameliorates the AOM/DSS induced carcinogenesis. Ilexgenin A can regulate lipid metabolism. Ilexgenin A decreases the expression of SREBP-1 and HIF 1α in AOM/DSS mice[1]. |
|
|